Hybrid and Chimeric Heterocycles: A Promising Approach to Synthesizing Biologically Active Compounds
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: 25 December 2025 | Viewed by 767
Special Issue Editor
Interests: heterocycles; medicinal chemistry; anticancer; antituberculosis; microwave; ultrasounds; organic synthesis
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
A literature survey revealed that heterocycles are privileged core scaffolds in medicinal chemistry, playing an essential role in drug design and reported to exhibit many biological and pharmacological activities, including antimicrobial, antiviral, anthelmintic, anti-HIV, anticancer, antiallergic, diuretics, cardiotonics, antihypertensive, antiplatelet, analgesic, anxiolytic, antidepressant, hypnotic sedative, antineurodegenerative, anti-Alzheimer’s, etc.
Despite the recent progress in obtaining new drugs with various biological activities in medicinal chemistry, there is an urgent need, in both the pharmaceutical industry and society, for new drugs with better activity, lower toxicity and enhanced properties. One of the most promising approaches used by scientists in the design of new drugs is the Multiple Targeting Drugs (MTD) approach, where a single chemical structure interacts with two or more distinct biological targets associated with a disease, resulting in new drug candidates with improved pharmacodynamic, pharmacokinetic and toxicologic properties and better patient compliance. Usually drug candidates in the Multiple Targeting Drugs approach are classified as Hybrid Drugs (HDs) or Chimeric Drugs (CDs). However, despite the advantages described above, both HDs and CDs have some drawbacks, such as decreases in target binding efficiency, side effects, toxicity, etc.
The aim of this Special Issue is to present the latest developments in biologically active compounds with a hybrid and/or chimeric heterocyclic core, with a focus on the synthesis, structure and biological activity of these compounds.
Prof. Dr. Ionel Mangalagiu
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- hybrid heterocyclic compounds
- chimeric heterocyclic compounds
- multifactorial diseases
- multiple targeting drugs
- biological activity: antimicrobials, antiviral, anthelmintic, anti-HIV, anticancer, antiallergic, diuretics, cardiotonic, antihypertensive, antiplatelet, analgesic, anxiolytics, antidepressant, hypnotic sedative, antineurodegenerative, anti-Alzheimer’s etc.
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
